Cite
Market access of engineered cell and gene therapies across Europe, the US and Canada: challenges, trends and solutions
MLA
van Overbeeke, Eline, et al. Market Access of Engineered Cell and Gene Therapies across Europe, the US and Canada: Challenges, Trends and Solutions. Dec. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2101..fca7fb88e199176dec48eb44a3432ad0&authtype=sso&custid=ns315887.
APA
van Overbeeke, E., Michelsen, S., Toumi, M., Stevens, H., Trusheim, M., Meslin, E., Simoens, S., & Huys, I. (2020). Market access of engineered cell and gene therapies across Europe, the US and Canada: challenges, trends and solutions.
Chicago
van Overbeeke, Eline, Sissel Michelsen, Mondher Toumi, Hilde Stevens, M Trusheim, E Meslin, Steven Simoens, and Isabelle Huys. 2020. “Market Access of Engineered Cell and Gene Therapies across Europe, the US and Canada: Challenges, Trends and Solutions,” December. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2101..fca7fb88e199176dec48eb44a3432ad0&authtype=sso&custid=ns315887.